FDA UDI In Commercial Distribution 🇺🇸 United States

Transpara

DI: 08719326450131 · Model: 1.7.y · Screenpoint Medical B.V.
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Basic Information

Brand Name
Transpara
Primary DI
08719326450131
Version / Model
1.7.y
Company Name
Screenpoint Medical B.V.
Labeler DUNS
491352982
Distribution Status
In Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2021-07-23
Public Version
1
Public Version Date
2021-08-02
Public Version Status
New
Public Device Record Key
38bf96a1-63bc-46e7-8254-3da63e9072f5

Device Description

Transpara® software is intended for use as a concurrent reading aid for physicians interpreting screening full-field digital mammography exams and digital breast tomosynthesis exams from compatible FFDM and DBT systems, to identify regions suspicious for breast cancer and assess their likelihood of malignancy. Output of the device includes locations of calcifications groups and soft-tissue regions, with scores indicating the likelihood that cancer is present, and an exam score indicating the likelihood that cancer is present in the exam. Patient management decisions should not be made solely on the basis of analysis by Transpara®.

Device Characteristics

Single Use
No
Prescription Use (Rx)
No
Over the Counter (OTC)
No
Kit
No
Combination Product
No
HCT/P
No
Contains NRL
No
Not Made with NRL
No
MRI Safety
Labeling does not contain MRI Safety Information
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
Yes
Has Lot/Batch Number
Yes
Has Manufacturing Date
No
Has Expiration Date
No
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
QDQ Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer

GMDN Terms

Code Name
63386 X-ray image interpretive software

Identifiers

Type ID
Primary 08719326450131

Premarket Submissions

Submission Number Supplement Number
K210404 000